252 related articles for article (PubMed ID: 18757301)
1. Antitumoral activity and osteogenic potential of mesenchymal stem cells expressing the urokinase-type plasminogen antagonist amino-terminal fragment in a murine model of osteolytic tumor.
Fritz V; Noël D; Bouquet C; Opolon P; Voide R; Apparailly F; Louis-Plence P; Bouffi C; Drissi H; Xie C; Perricaudet M; Müller R; Schwarz E; Jorgensen C
Stem Cells; 2008 Nov; 26(11):2981-90. PubMed ID: 18757301
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.
Feeley BT; Krenek L; Liu N; Hsu WK; Gamradt SC; Schwarz EM; Huard J; Lieberman JR
Bone; 2006 Feb; 38(2):154-66. PubMed ID: 16126463
[TBL] [Abstract][Full Text] [Related]
3. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors.
Gutova M; Najbauer J; Frank RT; Kendall SE; Gevorgyan A; Metz MZ; Guevorkian M; Edmiston M; Zhao D; Glackin CA; Kim SU; Aboody KS
Stem Cells; 2008 Jun; 26(6):1406-13. PubMed ID: 18403751
[TBL] [Abstract][Full Text] [Related]
4. The effect of cyclooxygenase-2 (COX-2) inhibition on human prostate cancer induced osteoblastic and osteolytic lesions in bone.
Gamradt SC; Feeley BT; Liu NQ; Roostaeian J; Lin YQ; Zhu LX; Sharma S; Dubinett SM; Lieberman JR
Anticancer Res; 2005; 25(1A):107-15. PubMed ID: 15816526
[TBL] [Abstract][Full Text] [Related]
5. Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy.
Uchibori R; Okada T; Ito T; Urabe M; Mizukami H; Kume A; Ozawa K
J Gene Med; 2009 May; 11(5):373-81. PubMed ID: 19274675
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice.
Li H; Lu H; Griscelli F; Opolon P; Sun LQ; Ragot T; Legrand Y; Belin D; Soria J; Soria C; Perricaudet M; Yeh P
Gene Ther; 1998 Aug; 5(8):1105-13. PubMed ID: 10326034
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
[TBL] [Abstract][Full Text] [Related]
8. Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells.
Kanehira M; Xin H; Hoshino K; Maemondo M; Mizuguchi H; Hayakawa T; Matsumoto K; Nakamura T; Nukiwa T; Saijo Y
Cancer Gene Ther; 2007 Nov; 14(11):894-903. PubMed ID: 17693990
[TBL] [Abstract][Full Text] [Related]
9. Composite implantation of mesenchymal stem cells with endothelial progenitor cells enhances tissue-engineered bone formation.
Usami K; Mizuno H; Okada K; Narita Y; Aoki M; Kondo T; Mizuno D; Mase J; Nishiguchi H; Kagami H; Ueda M
J Biomed Mater Res A; 2009 Sep; 90(3):730-41. PubMed ID: 18570318
[TBL] [Abstract][Full Text] [Related]
10. Comparison of multipotent differentiation potentials of murine primary bone marrow stromal cells and mesenchymal stem cell line C3H10T1/2.
Zhao L; Li G; Chan KM; Wang Y; Tang PF
Calcif Tissue Int; 2009 Jan; 84(1):56-64. PubMed ID: 19052794
[TBL] [Abstract][Full Text] [Related]
11. The effects of RANK blockade and osteoclast depletion in a model of pure osteoblastic prostate cancer metastasis in bone.
Whang PG; Schwarz EM; Gamradt SC; Dougall WC; Lieberman JR
J Orthop Res; 2005 Nov; 23(6):1475-83. PubMed ID: 16005175
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of prostate cancer neovascularization and growth by urokinase-plasminogen activator receptor blockade.
Evans CP; Elfman F; Parangi S; Conn M; Cunha G; Shuman MA
Cancer Res; 1997 Aug; 57(16):3594-9. PubMed ID: 9270033
[TBL] [Abstract][Full Text] [Related]
13. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury.
Banas A; Teratani T; Yamamoto Y; Tokuhara M; Takeshita F; Osaki M; Kawamata M; Kato T; Okochi H; Ochiya T
Stem Cells; 2008 Oct; 26(10):2705-12. PubMed ID: 18535155
[TBL] [Abstract][Full Text] [Related]
14. A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma.
Gunn WG; Conley A; Deininger L; Olson SD; Prockop DJ; Gregory CA
Stem Cells; 2006 Apr; 24(4):986-91. PubMed ID: 16293576
[TBL] [Abstract][Full Text] [Related]
15. Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases.
Margheri F; D'Alessio S; Serratí S; Pucci M; Annunziato F; Cosmi L; Liotta F; Angeli R; Angelucci A; Gravina GL; Rucci N; Bologna M; Teti A; Monia B; Fibbi G; Del Rosso M
Gene Ther; 2005 Apr; 12(8):702-14. PubMed ID: 15674398
[TBL] [Abstract][Full Text] [Related]
16. Bone-metastatic prostate carcinoma favors mesenchymal stem cell differentiation toward osteoblasts and reduces their osteoclastogenic potential.
Fritz V; Brondello JM; Gordeladze JO; Reseland JE; Bony C; Yssel H; Noël D; Jorgensen C
J Cell Biochem; 2011 Nov; 112(11):3234-45. PubMed ID: 22009438
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of posterolateral spinal fusion using mesenchymal stem cells: differences with or without osteogenic differentiation.
Nakajima T; Iizuka H; Tsutsumi S; Kayakabe M; Takagishi K
Spine (Phila Pa 1976); 2007 Oct; 32(22):2432-6. PubMed ID: 18090081
[TBL] [Abstract][Full Text] [Related]
18. IGF-I secretion by prostate carcinoma cells does not alter tumor-bone cell interactions in vitro or in vivo.
Rubin J; Fan X; Rahnert J; Sen B; Hsieh CL; Murphy TC; Nanes MS; Horton LG; Beamer WG; Rosen CJ
Prostate; 2006 Jun; 66(8):789-800. PubMed ID: 16482567
[TBL] [Abstract][Full Text] [Related]
19. Role of Wnts in prostate cancer bone metastases.
Hall CL; Kang S; MacDougald OA; Keller ET
J Cell Biochem; 2006 Mar; 97(4):661-72. PubMed ID: 16447163
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous graft of D1 mouse mesenchymal stem cells leads to the formation of a bone-like structure.
Juffroy O; Noël D; Delanoye A; Viltart O; Wolowczuk I; Verwaerde C
Differentiation; 2009 Nov; 78(4):223-31. PubMed ID: 19682787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]